ArcherDX Announces Expansion of Executive Leadership Team as Company Continues to Experience Rapid Growth March 5, 2019
KalVista Pharmaceuticals Presents Data at the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting February 25, 2019
Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis February 21, 2019
